Fiduciary Management Inc. WI cut its position in shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 0.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,047,181 shares of the software maker’s stock after selling 36,355 shares during the quarter. Fiduciary Management Inc. WI owned 3.35% of Allscripts Healthcare Solutions worth $86,051,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Wesbanco Bank Inc. grew its position in Allscripts Healthcare Solutions by 131.4% during the second quarter. Wesbanco Bank Inc. now owns 147,587 shares of the software maker’s stock worth $1,883,000 after buying an additional 83,807 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Allscripts Healthcare Solutions by 26.9% during the second quarter. Dimensional Fund Advisors LP now owns 9,171,285 shares of the software maker’s stock worth $117,026,000 after buying an additional 1,943,496 shares in the last quarter. Victory Capital Management Inc. grew its position in Allscripts Healthcare Solutions by 6.8% during the second quarter. Victory Capital Management Inc. now owns 1,627,164 shares of the software maker’s stock worth $20,763,000 after buying an additional 103,395 shares in the last quarter. Royal Bank of Canada grew its position in Allscripts Healthcare Solutions by 53.3% during the second quarter. Royal Bank of Canada now owns 955,183 shares of the software maker’s stock worth $12,189,000 after buying an additional 331,967 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. grew its position in Allscripts Healthcare Solutions by 1.0% during the third quarter. Fuller & Thaler Asset Management Inc. now owns 5,062,035 shares of the software maker’s stock worth $72,033,000 after buying an additional 49,823 shares in the last quarter.

In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $13.56, for a total transaction of $203,400.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP James Hewitt sold 36,796 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $14.11, for a total transaction of $519,191.56. Following the completion of the transaction, the senior vice president now owns 181,766 shares of the company’s stock, valued at approximately $2,564,718.26. The disclosure for this sale can be found here. Insiders have sold 71,796 shares of company stock worth $992,992 over the last ninety days. Company insiders own 0.91% of the company’s stock.

Shares of Allscripts Healthcare Solutions Inc (MDRX) opened at $13.97 on Wednesday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.98 and a current ratio of 0.98. The firm has a market capitalization of $2,563.86, a P/E ratio of 33.00, a price-to-earnings-growth ratio of 2.53 and a beta of 1.34. Allscripts Healthcare Solutions Inc has a 1-year low of $10.19 and a 1-year high of $14.51.

A number of research firms recently weighed in on MDRX. Dougherty & Co reissued a “buy” rating and set a $16.00 target price (up from $15.00) on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 3rd. Zacks Investment Research downgraded Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research report on Tuesday, October 10th. Robert W. Baird reissued a “buy” rating and set a $16.00 target price on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 17th. Royal Bank Of Canada began coverage on Allscripts Healthcare Solutions in a research report on Tuesday, September 19th. They set an “outperform” rating and a $17.00 target price on the stock. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $17.00 target price on shares of Allscripts Healthcare Solutions in a research report on Wednesday, September 27th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and eleven have issued a buy rating to the company. Allscripts Healthcare Solutions presently has an average rating of “Hold” and an average price target of $15.06.

ILLEGAL ACTIVITY WARNING: “Fiduciary Management Inc. WI Sells 36,355 Shares of Allscripts Healthcare Solutions Inc (MDRX)” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/12/06/fiduciary-management-inc-wi-sells-36355-shares-of-allscripts-healthcare-solutions-inc-mdrx.html.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related stocks with our FREE daily email newsletter.